Neonatal Cardio-Pulmonary Outcome Measure
N-COM
Scale Development ,Content Validation and Reliability Testing of Neonatal Cardio-pulmonary Outcome Measure (N-COM) in Neonates Admitted in Neonatal Intensive Care Unit
N-COM
Scale Development ,Content Validation and Reliability Testing of Neonatal Cardio-pulmonary Outcome Measure (N-COM) in Neonates Admitted in Neonatal Intensive Care Unit
Sponsor study identifier
Secondary identifiers
OTHER · Universal Trial Number (UTN) by WHO ICTRP
observational
30
1 country
1
Study Start
August 31, 2020
Actual (reported)Primary Completion
March 25, 2021
Actual (reported)Study Completion
March 31, 2021
Actual (reported)Neonatal Cardio-Pulmonary outcome measure (N-COM) will be used to assess the overall status of pulmonary and cardiac vascular system of neonates in Neonatal Intensive Care Unit (NICU). There are many scales available which are helpful for assessing behavior, pain, and neurological status of neonates but there is no scale available till now which can help to assess cardio-pulmonary status of neonates.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 31, 2021
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 6, 2020
Actual (reported)March 27, 2020
Actual (reported)August 31, 2020
Actual (reported)March 25, 2021
Actual (reported)March 31, 2021
Actual (reported)Change in Neonatal Cardio-pulmonary outcome measure (N-COM)
Changes in pre and post Neonatal-cardio-pulmonary outcome measure (N-COM) will be noted. In pulmonary system, cyanosis (peripheral and central cyanosis), nasal grunting, chest retractions, respiratory rate, SPO2, nasal flaring, chest symmetry etc will be checked. In the cardiovascular system, heart rate, pulse rate, congenital heart defects, chest symmetry, heart sounds etc will be checked.
Baseline, PRE INTERVENTION, 1 year POST INTERVENTION
Neonatal cardio-pulmonary outcome measure will be used to assess overall status of pulmonaryand cardio-vascular system
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Neonates who are suffering from cardio-pulmonary conditions will be taken in the study such as- Respiratory distress syndrome, Pneumonia, Congenital heart defects etc.
Maharishi Markandeshwar (M.M) Hospital, Mullana, Ambala, Haryana
Mullana, Haryana, 133207, India
Asir J Samuel, MPT, PhD
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
Pooja Mehra, BPT, (MPT)
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
Neha Sharma, MPT
Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation
30 participants (actual enrollment reported by the registry).
First Submitted
March 6, 2020
First Posted
March 27, 2020
Study Start
August 31, 2020
Actual (reported)Xeltis Pulmonary Valved Conduit Safety and Performance Study
Contact the study team to confirm eligibility.
Primary Completion
March 25, 2021
Actual (reported)Study Completion
March 31, 2021
Actual (reported)Last Updated
April 8, 2021
Record last verified: 2021-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: